BEKIR TANRIOVER, M



BEKIR TANRIOVER, M.D.

Curriculum Vitae

MAILING ADDRESS 323 Maple Street

Richardson, TX 75081

Cell Phone: (214) 597-7918

drtanriover@

CITIZENSHIP Turkey and the United States of America

DATE OF BIRTH 09/10/1969

MARITAL STATUS Married

EDUCATION 07/03 to 06/04 Vanderbilt University

Nashville, TN

Renal Transplantation Fellowship

10/98 to 12/00 University of Alabama at Birmingham

Birmingham, AL

Nephrology Fellowship

10/95 to 09/98 Tulane University Medical School

New Orleans, LA

Internal Medicine Internship/Residency

06/94 to 09/95 Hacettepe University Medical School

Ankara, Turkey

Clinical Microbiology and Infectious Diseases Residency

09/86 to 07/93 Hacettepe University Faculty of Medicine

Ankara, Turkey

Medical Doctor

EXPERIENCE 07/04 to Present Dallas Nephrology Associates

Nephrology/Transplantation

Dallas, TX

07/01 to 04/03 ICU Nephrology Consultant

Istanbul Memorial Hospital

Istanbul – Turkey

APPOINTMENTS 01/09 to 01/2013 NephSAP Reviewer

American Society of Nephrology

05/07 to Present Medical Director for Pancreas and

Combined-Kidney/Pancreas Transplantation

Methodist Dallas Medical Center

10/05 to 08/07 Novartis Advisory Board for ERLUS02 Study

08/04 to Present Clinical instructor for Nephrology Fellows (UTSW), Internal Medicine Residents (MDMC), Nurse Practioners (UTA)

COMMITTEES 10/07 to present PCAR Committee

Methodist Dallas Medical Center

02/05 to present Liver Transplant Selection Committee

Methodist Dallas Medical Center

08/04 to present Kidney Transplant Selection Committee

Methodist Dallas Medical Center

PUBLICATIONS

1) Tanriover B, Mejia A, Foster SV, Mubarak A. Primary Hyperoxaluria Involving Liver and Hepatic Artery: Images of an Aggressive Disease. (Considered for the publication after the completion of the revision at the journal of “Nephrology Dialysis and Transplantation”).

2) Tanriover B, Wright S, Foster S, Roush K, Castillo-Lugo J, Fa K, Levy F, Mejia A. High-Dose Intravenous Immunoglobulin and Rituximab Treatment for Antibody Mediated Rejection after Kidney Transplantation and a Cost Analysis. Transplantation Proceedings 2008, 40 (10): 3393-3396.

3) Tanriover B, Mejia A, Weinstein J, Foster S, Ghalib R, Mubarak A, Cheng S. A New Look to Combined Liver Kidney Allocation in the Post-MELD Era with Kidney Biopsy and GFR Measurement. Transplantation 2008: 86 (11):1548-53.

4) Wright S, Shaikh ZHA, Castillo-Lugo J, Tanriover B. Aseptic meningitis and abducens nerve palsy as a serious side effect of high dose intravenous immunoglobulin used in a patient with renal transplantation. Case Report. Transplant Infectious Disease 2008, 10(4):294-7.

5) Bolin P, Tanriover B, Zibari G, Lynn M, Pirsch J, Chan L, Cooper M, Langone A, Tomlanovich S. Improvement in 3-Month Patient-Reported Gastrointestinal Symptoms after Conversion from Mycophenolate Mofetil to Enteric-Coated Mycophenolate Sodium in Renal Transplant Patients. Transplantation 2007; 84:1443-1451.

6) Tanriover B, Chuang P, Fishbach B, Helderman J, Kizilisik T, Nylander W, Shaffer D and Langone A. Polyclonal Antibody-Induced Serum Sickness in Renal Transplant Recipients: Treatment with Therapeutic Plasma Exchange. Transplantation 2005; 80:279-281.

7) Ramanathan V, Goral S, Tanriover B, Feurer I, Kazancioglu R, Shaffer D, Helderman J. Screening Asymptomatic Diabetic Patients for Coronary Artery Disease Prior to Renal Transplantation. Transplantation 2005; 10:1453-1458, 2005.

8) H. Arbatlı, E. Demirsoy, O. Yılmaz, M. Ünal, N. Yağan, M. Arpaz, B. Tanriover, F. Tükenmez, B. Sönmez. Outcomes of CABG Surgery in 17 Patients With ESRD. Turkish Journal of Dialysis Transplantation and Burn 2003;14(3) 177-182.

9) Tanriover B, Carlton D, Allon M. Bacteremia Associated with Tunneled Dialysis Catheters: Comparison of Two Treatment Strategies. Kidney Int 2000; 57:2151-55.

10) Tanriover B, Tuncer S. Human Immunodeficiency Virus and its Genetics. Turkish Journal of Biology 1997; 21:505-514.

11) Taniyuksel M, Erguven S, Tanriover B. Comparison of the Serologic Tests (IFA, ELISA) with Microscopy Use for the Diagnosis of Amoebosis. Turkish Journal of Parasitology 1995 19(4):476-482.

12) Tanriover B. The Role of the Helicobacter pylori in the Pathogenesis of Gastric Lymphoma. Turkish Journal of Hematology and Oncology 1995: 5(1):44-47.

ABSTRACTS

1) Tanriover B, Wright S. High Dose IVIG and Anti-CD20 Antibody for Antibody Mediated Rejection Treatment without Plasmapheresis. AST Winter Meeting, Banff, Canada, March 2009.

2) Tanriover B, Wright S, Foster S, Roush K, Castillo-Lugo J, Fa K, Levy F, Mejia A. Outcome of Antibody Mediated Rejection Treatment with High Dose IVIG and Anti-CD20 Antibody. Am J Transpl 8 Suppl. 2:580, April 2008.

3) Tanriover B, Mejia A, Weinstein J, Foster S, Ghalib R, Mubarak A, Cheng S. Analysis of Renal Function Assessment and Renal Biopsy Data in Liver Failure Patients with Renal Dysfunction. A New Look to Combined Liver Kidney Transplantation Work up Algorithm; Single Center Experience. Am J Transpl 8 Suppl. 2:337, April 2008.

4) Friedman, D, Rashdan, S, Levine, C, Weinstein, J, Schwartz, A., Tanriover, B, Ghalib, R. Efficacy and Safety of Peg IFN alfa-2a and Low Dose Ribavirin in ESRD Patients with Hepatitis C.  Digestive Disease Week, Washington, DC, May 2007.

5) Tomlanovich S, Bolin P, Tanriover B. A Three-Month, Prospective, Open-Label, Two Cohort Study to Investigate the Efficacy, Safety and Tolerability of EC-MPS in Combination with Cyclosporin or Tacrolimus in Renal Transplant Recipients With GI Intolerance. Am J Transpl 6 Suppl. 2:487, August 2006.

6) Bolin P, Tanriover B, Lynn M. Significant Improvement of GI Symptom Burden in African American Transplant Recipients After Conversion of EC-MPS. Am J Transpl 6 Suppl. 2:514, August 2006.

7) Tanriover B, Guay-Woodford LM. Single Nucleotide Polymorphism (SNP) – Based Genome Scan for a Novel Glomerulocystic Kidney Disease (GCKD) Locus. J Am Soc Nephrol 11:399A, 2000.

8) Tanriover B, Carlton D, Allon M. Treatment Options for Bacteremia Associated with Tunneled-Cuffed Venous Hemodialysis Catheters. J Am Soc Nephrol 10:219A, 1999.

ORAL PRESENTATIONS

Sociedad de Nefrología e Hipertensión de Puerto Rico, Fajardo, PR

July 24-28, 2008

□ Liver/Kidney Transplant: Are Two Really Better than One?

NATCO 2007 Annual Meeting, New York City, August 12-14, 2007

□ Liver/Kidney Transplant: Are Two Really Better than One?

□ Turkish Overview Regarding Donation and Transplantation

92nd Annual Scientific Assembly of Southern Medical Association;

New Orleans, LA, November 20, 1998

□ Pulmonary Arterial Compression Secondary to Mediastinal Lymphadenopathy of Sarcoidosis Presenting as High-Probability V/Q Mismatch.

□ Massive Hemoptysis Secondary to a Bronchogenic Carcinoma Invading the Left Pulmonary Artery

CERTIFICATIONS

Qualified for Medical License from the Texas State Board of Medical Examiners

on June 6, 2003, (holding active license)

Qualified for Medical License from the Tennessee State Board of Medical Examiners on January 6, 2003 (holding active license)

Qualified for Medical License from the Louisiana State Board of Medical Examiners on July 18, 2000

Qualified for Medical License from the Alabama State Board of Medical Examiners on July 22, 1998

Qualified for ECFMG Certificate on July 5, 1995

ABIM, Board Certified in Nephrology in November 2000

ABIM, Board Certified in Internal Medicine in August 1999

MEMBERSHIPS

American College of Physician

American Society of Nephrology

American Society of Transplantation

................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download